Mellozzan (Melatonin)

Melatonin, the active ingredient in Mellozzan, is a melatonin receptor agonist presented as an oral formulation for oral use. It is used to help regulate sleep patterns in adults experiencing insomnia, jet lag, or circadian rhythm sleep‑wake disorders. GNH USA supplies Mellozzan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Mellozzan is a melatonin receptor agonist indicated for sleep‑related conditions. - Insomnia: helps initiate and maintain sleep in individuals with difficulty falling asleep. - Jet lag: assists in adjusting the internal clock after rapid east‑west travel, reducing sleep disruption. - Circadian rhythm sleep‑wake disorders: supports alignment of the sleep‑wake cycle in shift‑work or delayed sleep phase syndrome.

Melatonin is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Drowsiness: feeling unusually sleepy during the day. - Headache: mild to moderate headache after administration. - Dizziness: sensation of light‑headedness or imbalance. - Nausea: mild stomach discomfort or queasiness.

Serious or Rare Side Effects: - Allergic reaction: rash, itching, swelling, or difficulty breathing. - Mood changes: depression or increased anxiety in susceptible individuals. - Hormonal effects: rare alterations in reproductive hormone levels.

When using Mellozzan, consider the following safety measures. - Pregnancy: consult a healthcare professional before use, as safety data are limited. - Breastfeeding: discuss potential risks with a physician, as melatonin may pass into breast milk. - Driving: avoid operating machinery or driving if drowsiness occurs. - Interactions: review concomitant medications with a pharmacist to prevent adverse effects. - Store at ambient temperature: keep below 25°C in the original container, protect from moisture and direct sunlight.

Melatonin may interact with several drug classes.

Major Interactions (Avoid): - Anticoagulants: may increase bleeding risk when combined with warfarin or similar agents. - Immunosuppressants: could reduce efficacy of drugs such as cyclosporine.

Moderate Interactions (Monitor Closely): - Sedatives: additive drowsiness when taken with benzodiazepines or antihistamines. - Antidepressants: possible alteration of serotonergic activity with SSRIs or MAO inhibitors. - Oral contraceptives: may affect hormone metabolism, requiring monitoring.